World’s top cancer drug group sees China sales grow more than 50% in a year
Michael Nawrath
Cancer drug specialist says it will review R&D programme after second high profile setback for its pipeline
YOU MAY ALSO LIKE...
Crosswords & puzzles to keep you challenged and entertained
Follow all the action from this year's championship
Start The Search For Your Next Job
Latest news and analysis on the battle to save the planet
A project examining attitudes about the future of Ireland
Weddings, Births, Deaths and other family notices